What minimally invasive therapy uses low-wave radio frequency to destroy prostate tissue in the treatment of BPH?

Transurethral needle ablation (TUNA) employs low-wave radio frequency to specifically target and destroy excess prostate tissue associated with Benign Prostatic Hyperplasia (BPH). This method involves the insertion of needles transurethrally, which deliver radiofrequency energy to the prostate tissue, leading to its ablation. The minimally invasive nature of TUNA means it generally results in less bleeding, shorter recovery times, and a lower risk of complications compared to more invasive procedures.

The other options listed, while related to prostate treatments, do not utilize low-wave radio frequency for BPH. Laser prostatectomy employs laser energy for tissue removal, while Transurethral resection of the prostate (TURP) involves a telescopic resection using a cutting tool. Radioactive seed implantation is a form of brachytherapy used for prostate cancer treatment rather than for BPH. Thus, TUNA is correctly identified as the therapy utilizing low-wave radio frequency for this specific condition.